Showing results (71-80 of 559) with videos related to
Sort By:
Pageof 56
Journal of the American College of Cardiology|October 16, 2010
Prior aspirin use and outcomes in acute coronary syndromesJonathan D Rich, Christopher P Cannon, Sabina A Murphy, et al.Journal of the American College of Cardiology|May 17, 2005
Relative efficacy of atorvastatin 80 mg and pravastatin 40 mg in achieving the dual goals of low-density lipoprotein cholesterol <70 mg/dl and C-reactive protein <2 mg/l: an analysis of the PROVE-IT TIMI-22 trialPaul M Ridker, David A Morrow, Lynda M Rose, et al.American Heart Journal|August 25, 2009
Detection of myocardial injury in patients with unstable angina using a novel nanoparticle cardiac troponin I assay: observations from the PROTECT-TIMI 30 TrialSean R Wilson, Marc S Sabatine, Eugene Braunwald, et al.Journal of the American Heart Association|March 26, 2013
Dynamic TIMI risk score for STEMISameer T Amin, David A Morrow, Eugene Braunwald, et al.European Heart Journal|February 25, 2011
Prognostic utility of neopterin and risk of heart failure hospitalization after an acute coronary syndromeBabak Nazer, Kausik K Ray, Sarah Sloan, et al.Circulation|May 9, 2002
Relationship of the TIMI myocardial perfusion grades, flow grades, frame count, and percutaneous coronary intervention to long-term outcomes after thrombolytic administration in acute myocardial infarctionC Michael Gibson, Christopher P Cannon, Sabina A Murphy, et al.Circulation|May 23, 2007
Outcomes and optimal antithrombotic therapy in women undergoing fibrinolysis for ST-elevation myocardial infarctionJessica L Mega, David A Morrow, Erika Ostör, et al.JAMA Cardiology|August 14, 2020
Cost-effectiveness of Sacubitril-Valsartan in Hospitalized Patients Who Have Heart Failure With Reduced Ejection FractionThomas A Gaziano, Gregg C Fonarow, Eric J Velazquez, et al.Journal of the American College of Cardiology|October 18, 2005
Can low-density lipoprotein be too low? The safety and efficacy of achieving very low low-density lipoprotein with intensive statin therapy: a PROVE IT-TIMI 22 substudyStephen D Wiviott, Christopher P Cannon, David A Morrow, et al.The American Journal of Cardiology|August 6, 2011
Efficacy and safety of intensive antiplatelet therapy with prasugrel from TRITON-TIMI 38 in a core clinical cohort defined by worldwide regulatory agenciesStephen D Wiviott, Nihar Desai, Sabina A Murphy, et al.Pageof 56